Strategies for generating mouse model resources of human disease
Accepted date: 12 Feb 2023
Copyright
Jirong Pan , Ling Zhang , Zhibing Huang , Dalu Zhao , He Li , Yanan Fu , Meng Wang , Borui Chen , Fuad A. Iraqi , Grant Morahan , Chuan Qin . Strategies for generating mouse model resources of human disease[J]. Protein & Cell, 2023 , 14(12) : 866 -870 . DOI: 10.1093/procel/pwad011
| 1 |
Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64–74.
|
| 2 |
Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1:213–216.
|
| 3 |
Bufi R, Korstanje R. The impact of genetic background on mouse models of kidney disease. Kidney Int 2022;102:38–44.
|
| 4 |
Cao J, Pan J, Zhang D et al. Effects of interleukin-6 gene knockout on β-amyloid deposition and cognition in 5× FAD mouse model of Alzheimer’s disease. Acta Acad Med Sin 2022;44: 357–365.
|
| 5 |
Churchill GA, Airey DC, Allayee H et al. Complex Trait Consortium. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004;36:1133–1137.
|
| 6 |
Gurumurthy CB, Saunders TL, Ohtsuka M. Designing and generating a mouse model: frequently asked questions. J Biomed Res 2021;35:76–90.
|
| 7 |
Hirabayashi N, Hata J, Ohara T et al. Association Between Diabetes and Hippocampal Atrophy in Elderly Japanese: The Hisayama Study. Diabetes Care 2016;39:1543–1549.
|
| 8 |
Hyman BT, Phelps CH, Beach TG et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 2012;8:1–13.
|
| 9 |
Khera AV, Chaffin M, Aragam KG et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 2018;50:1219–1224.
|
| 10 |
Li W, Cao L, Li M et al. Novel spontaneous myelodysplastic syndrome mouse model. Animal Model Exp Med 2021;4:169–180.
|
| 11 |
Liu Y, Xu Y, Zhang L et al. Down-regulated drebrin aggravates cognitive impairments in a mouse model of Alzheimer’s disease. Int J Mol Sci 2017;18:800.
|
| 12 |
Lloyd KC. A knockout mouse resource for the biomedical research community. Ann N Y Acad Sci 2011;1245:24–26.
|
| 13 |
Newman AB, Fitzpatrick AL, Lopez O et al. Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 2005;53:1101–1107.
|
| 14 |
Oakley H, Cole SL, Logan S et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006;26:10129–10140.
|
| 15 |
Oddo S, Caccamo A, Shepherd JD et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409–421.
|
| 16 |
Pennisi M, Crupi R, Di Paola R et al. Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. J Neurosci Res 2017;95:1360–1372.
|
| 17 |
Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis 2017;1863:1037–1045.
|
| 18 |
Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 2016;8:595–608.
|
| 19 |
Sims-Robinson C, Kim B, Rosko A et al. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551–559.
|
| 20 |
Stöhr O, Schilbach K, Moll L et al. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease. Age 2013;35:83–101.
|
| 21 |
Stottmann, R., Beier, D. (2014). ENU mutagenesis in the mouse. Curr Protoc Hum Genet 82:15.4.1–15.4.10.
|
| 22 |
Su T, Liu H, Zhang D et al. LIM homeodomain transcription factor Isl1 affects urethral epithelium differentiation and apoptosis via Shh. Cell Death Dis 2019;10:713.
|
| 23 |
Svenson KL, Gatti DM, Valdar W et al. High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics 2012;190:437–447.
|
| 24 |
Takeda S, Sato N, Uchio-Yamada K et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 2010;107:7036–7041.
|
| 25 |
Threadgill DW, Miller DR, Churchill GA et al. The collaborative cross: a recombinant inbred mouse population for the systems genetic era. ILAR J 2011;52:24–31.
|
| 26 |
Visscher PM, Yengo L, Cox NJ et al. Discovery and implications of polygenicity of common diseases. Science 2021;373:1468–1473.
|
| 27 |
Weerasekera LY, Balmer LA, Ram R et al. Characterization of retinal vascular and neural damage in a novel model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2015;56:3721–3730.
|
| 28 |
Zhang J, Malo D, Mott R et al. Identification of new loci involved in the host susceptibility to Salmonella Typhimurium in collaborative cross mice. BMC Genomics 2018;19:303.
|
/
| 〈 |
|
〉 |